320 related articles for article (PubMed ID: 15317978)
21. Phosphate-modified analogues of m(7)GTP and m(7)Gppppm(7)G-Synthesis and biochemical properties.
Ziemniak M; Kowalska J; Lukaszewicz M; Zuberek J; Wnek K; Darzynkiewicz E; Jemielity J
Bioorg Med Chem; 2015 Sep; 23(17):5369-81. PubMed ID: 26264844
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes.
Kowalska J; Wypijewska del Nogal A; Darzynkiewicz ZM; Buck J; Nicola C; Kuhn AN; Lukaszewicz M; Zuberek J; Strenkowska M; Ziemniak M; Maciejczyk M; Bojarska E; Rhoads RE; Darzynkiewicz E; Sahin U; Jemielity J
Nucleic Acids Res; 2014; 42(16):10245-64. PubMed ID: 25150148
[TBL] [Abstract][Full Text] [Related]
23. m7GTP alphaS is a strong and stable inhibitor of cap-dependent translation.
Kowalska J; Lukaszewicz M; Zuberek J; Ziemniak M; Strenkowska M; Darzynkiewicz E; Jemielity J
Nucleic Acids Symp Ser (Oxf); 2008; (52):291-2. PubMed ID: 18776368
[TBL] [Abstract][Full Text] [Related]
24. Cap analogs containing 6-thioguanosine--reagents for the synthesis of mRNAs selectively photo-crosslinkable with cap-binding biomolecules.
Nowakowska M; Kowalska J; Martin F; d'Orchymont A; Zuberek J; Lukaszewicz M; Darzynkiewicz E; Jemielity J
Org Biomol Chem; 2014 Jul; 12(27):4841-7. PubMed ID: 24763507
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and properties of mRNAs containing the novel "anti-reverse" cap analogs 7-methyl(3'-O-methyl)GpppG and 7-methyl (3'-deoxy)GpppG.
Stepinski J; Waddell C; Stolarski R; Darzynkiewicz E; Rhoads RE
RNA; 2001 Oct; 7(10):1486-95. PubMed ID: 11680853
[TBL] [Abstract][Full Text] [Related]
26. Potential therapeutic applications of RNA cap analogs.
Ziemniak M; Strenkowska M; Kowalska J; Jemielity J
Future Med Chem; 2013 Jun; 5(10):1141-72. PubMed ID: 23795970
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and properties of mRNA cap analogs containing imidodiphosphate moiety--fairly mimicking natural cap structure, yet resistant to enzymatic hydrolysis.
Rydzik AM; Kulis M; Lukaszewicz M; Kowalska J; Zuberek J; Darzynkiewicz ZM; Darzynkiewicz E; Jemielity J
Bioorg Med Chem; 2012 Mar; 20(5):1699-710. PubMed ID: 22316555
[TBL] [Abstract][Full Text] [Related]
28. Chemical synthesis and binding activity of the trypanosomatid cap-4 structure.
Lewdorowicz M; Yoffe Y; Zuberek J; Jemielity J; Stepinski J; Kierzek R; Stolarski R; Shapira M; Darzynkiewicz E
RNA; 2004 Sep; 10(9):1469-78. PubMed ID: 15273325
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of potential inhibitors of eIF4E cap binding to 7-methyl GTP.
Ghosh P; Park C; Peterson MS; Bitterman PB; Polunovsky VA; Wagner CR
Bioorg Med Chem Lett; 2005 Apr; 15(8):2177-80. PubMed ID: 15808492
[TBL] [Abstract][Full Text] [Related]
30. The first examples of mRNA cap analogs bearing boranophosphate modification.
Kowalska J; Zuberek J; Darzynkiewicz ZM; Lukaszewicz M; Darzynkiewicz E; Jemielity J
Nucleic Acids Symp Ser (Oxf); 2008; (52):289-90. PubMed ID: 18776367
[TBL] [Abstract][Full Text] [Related]
31. Enzymatic synthesis of RNAs capped with nucleotide analogues reveals the molecular basis for substrate selectivity of RNA capping enzyme: impacts on RNA metabolism.
Issur M; Bougie I; Despins S; Bisaillon M
PLoS One; 2013; 8(9):e75310. PubMed ID: 24086504
[TBL] [Abstract][Full Text] [Related]
32. Truncated initiation factor eIF4G lacking an eIF4E binding site can support capped mRNA translation.
Ali IK; McKendrick L; Morley SJ; Jackson RJ
EMBO J; 2001 Aug; 20(15):4233-42. PubMed ID: 11483526
[TBL] [Abstract][Full Text] [Related]
33. Locked nucleic acid (LNA)-modified dinucleotide mRNA cap analogue: synthesis, enzymatic incorporation, and utilization.
Kore AR; Shanmugasundaram M; Charles I; Vlassov AV; Barta TJ
J Am Chem Soc; 2009 May; 131(18):6364-5. PubMed ID: 19385620
[TBL] [Abstract][Full Text] [Related]
34. Crystallographic and mass spectrometric characterisation of eIF4E with N7-alkylated cap derivatives.
Brown CJ; McNae I; Fischer PM; Walkinshaw MD
J Mol Biol; 2007 Sep; 372(1):7-15. PubMed ID: 17631896
[TBL] [Abstract][Full Text] [Related]
35. Five eIF4E isoforms from Arabidopsis thaliana are characterized by distinct features of cap analogs binding.
Kropiwnicka A; Kuchta K; Lukaszewicz M; Kowalska J; Jemielity J; Ginalski K; Darzynkiewicz E; Zuberek J
Biochem Biophys Res Commun; 2015 Jan; 456(1):47-52. PubMed ID: 25446076
[TBL] [Abstract][Full Text] [Related]
36. A mutant of eukaryotic protein synthesis initiation factor eIF4E(K119A) has an increased binding affinity for both m7G cap analogues and eIF4G peptides.
Friedland DE; Wooten WN; LaVoy JE; Hagedorn CH; Goss DJ
Biochemistry; 2005 Mar; 44(11):4546-50. PubMed ID: 15766285
[TBL] [Abstract][Full Text] [Related]
37. Cap-binding protein 1-mediated and eukaryotic translation initiation factor 4E-mediated pioneer rounds of translation in yeast.
Gao Q; Das B; Sherman F; Maquat LE
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4258-63. PubMed ID: 15753296
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and application of a chain-terminating dinucleotide mRNA cap analog.
Peng ZH; Sharma V; Singleton SF; Gershon PD
Org Lett; 2002 Jan; 4(2):161-4. PubMed ID: 11796040
[TBL] [Abstract][Full Text] [Related]
39. Modified ARCA analogs providing enhanced translational properties of capped mRNAs.
Kocmik I; Piecyk K; Rudzinska M; Niedzwiecka A; Darzynkiewicz E; Grzela R; Jankowska-Anyszka M
Cell Cycle; 2018; 17(13):1624-1636. PubMed ID: 29954234
[TBL] [Abstract][Full Text] [Related]
40. Translation, stability, and resistance to decapping of mRNAs containing caps substituted in the triphosphate chain with BH3, Se, and NH.
Su W; Slepenkov S; Grudzien-Nogalska E; Kowalska J; Kulis M; Zuberek J; Lukaszewicz M; Darzynkiewicz E; Jemielity J; Rhoads RE
RNA; 2011 May; 17(5):978-88. PubMed ID: 21447710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
